JR-446

· JCR Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JR-446, covering 2025-09-02 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB [Phase 1, Phase 2]